← Back to Search

Behavioural Intervention

Med AAAction intervention for Stroke (MedAAAction Trial)

N/A

Recruiting

Led By Satya Surbhi, PhD

Research Sponsored by University of Tennessee

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

21 years or older

TennCare or uninsured inpatients

Timeline

Screening 3 weeks

Treatment Varies

Follow Up adherence measured at 3, 6, 9, and 12 months

Awards & highlights

MedAAAction Trial Summary

This trial aims to help low-income individuals with multiple chronic conditions improve their medication adherence after being discharged from the hospital. The study will test a new pharmacy-led intervention that includes providing medications with zero copay

Who is the study for?

This trial is for socioeconomically disadvantaged patients with multiple chronic conditions who have recently been discharged from the hospital. Participants must be Medicaid recipients or uninsured, and they should face challenges like financial issues, transportation difficulties, or systemic barriers to medication adherence.Check my eligibility

What is being tested?

The Med AAAction intervention is being tested against usual care in a pragmatic randomized controlled trial. It includes free medications, bedside and home delivery of meds, plus support from pharmacy techs/health coaches for better access to meds and primary care follow-up.See study design

What are the potential side effects?

Since this study focuses on improving medication adherence rather than testing new drugs, it does not directly involve side effects of interventions. However, participants may experience issues related to their existing medications.

MedAAAction Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

Select...

I am either uninsured or covered by TennCare.

Select...

I have 2 or more chronic conditions or take 2 or more medications for them.

MedAAAction Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ adherence measured at 3, 6, 9, and 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~adherence measured at 3, 6, 9, and 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and adherence measured at 3, 6, 9, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adherence to chronic disease medications

Secondary outcome measures

Cost

Health care utilization

Qualitative Evaluation

MedAAAction Trial Design

2Treatment groups

Active Control

Placebo Group

Group I: Med AAAction interventionActive Control1 Intervention

The Med AAAction intervention will include the following components: 1) medications with zero copay, 2) bedside delivery and subsequent home delivery of medications, and 3) care coordination provided by certified pharmacy technicians/health coaches to assist with medication access, medication reconciliation, and rapid and ongoing primary care follow-up after hospital discharge. The intervention will be provided for one-year.

Group II: Usual care InterventionPlacebo Group1 Intervention

As part of the usual care, the participating hospitals provide medication reconciliation services before hospital discharge. Usual care may also include MTM services for patients discharged on specialty medications or Medicare beneficiaries. Patients in both groups will receive financial incentives for completing their baseline survey ($15), and 3-month ($15), 6-month ($15), and 12-month ($25) follow-up visits.

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Sponsor GmbHOTHER

31 Previous Clinical Trials

9,846 Total Patients Enrolled

University of TennesseeLead Sponsor

189 Previous Clinical Trials

141,641 Total Patients Enrolled

1 Trials studying Stroke

182 Patients Enrolled for Stroke

Satya Surbhi, PhDPrincipal InvestigatorUTHSC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participants allowed to take part in this medical study?

"Affirmative. Details from clinicaltrials.gov confirm that this investigation is presently enrolling participants. The trial was initially shared on April 6, 2024, and last revised on April 15, 2024. Approximately 388 individuals are being sought across two designated locations for the study."

Answered by AI

Are potential participants currently able to apply for enrollment in this study?

"Yes, as per clinicaltrials.gov data, this current trial is actively seeking volunteers. It was initially posted on April 6th, 2024 and last revised on April 15th, 2024. The study aims to recruit a total of 388 participants across two designated sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence

2024. "Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06374277.

All > Pulmonary Embolism > Knoxville